Skip to main content
. 2024 May 16;16(10):1901. doi: 10.3390/cancers16101901

Table 1.

Measured concentrations (LC-MS/MS) of drugs in the tumor (median with 5–95% confidence interval).

Male (N = 4) BI-3406 (µM) Trametinib (µM) BKM120 (µM)
Median (5–95% CI) 2.4 (0.12–9.3) 0.21 (0.02–0.65) 2.1 (0.68–3.6)
Female (N = 6) BI-3406 (µM) Trametinib (µM) BKM120 (µM)
Median (5–95% CI) 3.8 (0.16–38) 0.16 (0.01–1.4) 2.4 (0.41–24)